Could 3D models of cancer enhance drug screening?
Open accessThe DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.
Abstract
Cancer is a multifaceted pathology, where cellular and acellular players interact to drive cancer progression and, in the worst-case, metastasis. The current methods to investigate the heterogeneous nature of cancer are inadequate, since they rely on 2D cell cultures and animal models. The cell line-based drug efficacy and toxicity assays are not able to predict the tumor response to anti-cancer agents and it is already widely discussed how molecular pathway are not recapitulated in vitro so called flat biology. On the other side, animal models often fail to detect the side-effects of drugs, mimic the metastatic progression or the interaction between cancer and immune system, due to biologic difference in human and animals. Moreover, ethical and regulatory issues limit animal experimentation. Every year pharma/biotech companies lose resources in drug discovery and testing processes that are successful only in 5% of the cases. There is an urgent need to validate accurate and predictive platforms in order to enhance drug-testing process taking into account the physiopathology of the tumor microenvironment. Three dimensional in vitro tumor models could enhance drug manufactures in developing effective drugs for cancer diseases. The 3D in vitro cancer models can improve the predictability of toxicity and drug sensitivity in cancer. Despite the demonstrated advantages of 3D in vitro disease systems when compared to 2D culture and animal models, they still do not reach the standardization required for preclinical trials. This review highlights in vitro models that may be used as preclinical models, accelerating the drug development process towards more precise and personalized standard of care for cancer patients. We describe the state-of-the art of 3D in vitro culture systems, with a focus on how these different approaches could be coupled in order to achieve a compromise between standardization and reliability in recapitulating tumor microenvironment and drug response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Innovation in the pharmaceutical industry: New estimates of R&D costs
DiMasi, J. A., Grabowski, H. G., & Hansen, R. W. (2016) · Journal of Health Economics · doi:10.1016/j.jhealeco.2016.01.012 · Cited by 3,359
Bhatia, S. N., & Ingber, D. E. (2014) · Nature Biotechnology · doi:10.1038/nbt.2989 · Cited by 3,305
Modeling Development and Disease with Organoids
Clevers, H. (2016) · Cell · doi:10.1016/j.cell.2016.05.082 · Cited by 3,196
Organogenesis in a dish: Modeling development and disease using organoid technologies
Lancaster, M. A., & Knoblich, J. A. (2014) · Science · doi:10.1126/science.1247125 · Cited by 2,931
The NCI60 human tumour cell line anticancer drug screen
Shoemaker, R. H. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1951 · Cited by 2,620
A living biobank of breast cancer organoids captures disease heterogeneity
Sachs, N., de Ligt, J., Kopper, O., Gogola, E., Bounova, G., Weeber, F., Balgobind, A. V., Wind, K., Gracanin, A., Begthel, H., et al. (2018) · Cell · doi:10.1016/j.cell.2017.11.010 · Cited by 1,973
Spheroid-based drug screen: Considerations and practical approach
Friedrich, J., Seidel, C., Ebner, R., & Kunz-Schughart, L. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.226 · Cited by 1,742
How does the extracellular matrix direct gene expression?
Bissell, M. J., Hall, H. G., & Parry, G. (1982) · Journal of Theoretical Biology · doi:10.1016/0022-5193(82)90388-5 · Cited by 1,522
Chen, F., Tillberg, P. W., & Boyden, E. S. (2015) · Science · doi:10.1126/science.1260088 · Cited by 1,501
2D and 3D Cell Cultures - a Comparison of Different Types of Cancer Cell Cultures
Kapałczyńska, M., Kolenda, T., Przybyła, W., Zajączkowska, M., Teresiak, A., Filas, V., Ibbs, M., Bliźniak, R., Łuczewski, Ł., & Lamperska, K. (2016) · Archives of Medical Science · doi:10.5114/aoms.2016.63743 · Cited by 1,499
Human primary liver cancer–derived organoid cultures for disease modeling and drug screening
Broutier, L., Mastrogiovanni, G., Verstegen, M. M., Francies, H. E., Gavarró, L. M., Bradshaw, C. R., Allen, G. E., Arnes-Benito, R., Sidorova, O., Gaspersz, M. P., et al. (2017) · Nature Medicine · doi:10.1038/nm.4438 · Cited by 1,471
Spheroid culture as a tool for creating 3D complex tissues
Fennema, E., Rivron, N., Rouwkema, J., van Blitterswijk, C., & de Boer, J. (2013) · Trends in Biotechnology · doi:10.1016/j.tibtech.2012.12.003 · Cited by 1,054
Lost in translation: animal models and clinical trials in cancer treatment.
(2014) · Europe PMC (PubMed Central) · Cited by 1,033
Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine
Pauli, C., Hopkins, B. D., Prandi, D., Shaw, R., Fedrizzi, T., Sboner, A., Sailer, V., Augello, M., Puca, L., Rosati, R., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-1154 · Cited by 937
Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer
Lee, S. H., Hu, W., Matulay, J. T., Silva, M. V., Owczarek, T. B., Kim, K., Chua, C. W., Barlow, L. J., Kandoth, C., Williams, A. B., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.017 · Cited by 873
Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function
Zervantonakis, I. K., Hughes-Alford, S. K., Charest, J. L., Condeelis, J. S., Gertler, F. B., & Kamm, R. D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210182109 · Cited by 872
Human 3D vascularized organotypic microfluidic assays to study breast cancer cell extravasation
Jeon, J. S., Bersini, S., Gilardi, M., Dubini, G., Charest, J. L., Moretti, M., & Kamm, R. D. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1417115112 · Cited by 723
Growth of Cell-strains and Primary Cells on Micro-carriers in Homogeneous Culture
VAN WEZEL, A. L. (1967) · Nature · doi:10.1038/216064a0 · Cited by 711
Novel trends in high-throughput screening
Mayr, L. M., & Bojanic, D. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.08.004 · Cited by 694
Yi, H.-G., Jeong, Y. H., Kim, Y., Choi, Y.-J., Moon, H. E., Park, S. H., Kang, K. S., Bae, M., Jang, J., Youn, H., et al. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0363-x · Cited by 634
Engineered In Vitro Disease Models
Benam, K. H., Dauth, S., Hassell, B., Herland, A., Jain, A., Jang, K.-J., Karalis, K., Kim, H. J., MacQueen, L., Mahmoodian, R., et al. (2015) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012414-040418 · Cited by 554
Three-dimensional printing of Hela cells for cervical tumor model in vitro
Zhao, Y., Yao, R., Ouyang, L., Ding, H., Zhang, T., Zhang, K., Cheng, S., & Sun, W. (2014) · Biofabrication · doi:10.1088/1758-5082/6/3/035001 · Cited by 534
Check your cultures! A list of cross‐contaminated or misidentified cell lines
Capes‐Davis, A., Theodosopoulos, G., Atkin, I., Drexler, H. G., Kohara, A., MacLeod, R. A. F., Masters, J. R., Nakamura, Y., Reid, Y. A., Reddel, R. R., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25242 · Cited by 520
Prasad, V., & Mailankody, S. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.3601 · Cited by 503
Boretto, M., Maenhoudt, N., Luo, X., Hennes, A., Boeckx, B., Bui, B., Heremans, R., Perneel, L., Kobayashi, H., Van Zundert, I., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0360-z · Cited by 503
Hoarau-Véchot, J., Rafii, A., Touboul, C., & Pasquier, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010181 · Cited by 489
Interconnected Microphysiological Systems for Quantitative Biology and Pharmacology Studies
Edington, C. D., Chen, W. L. K., Geishecker, E., Kassis, T., Soenksen, L. R., Bhushan, B. M., Freake, D., Kirschner, J., Maass, C., Tsamandouras, N., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-22749-0 · Cited by 487
Expansion microscopy: principles and uses in biological research
Wassie, A. T., Zhao, Y., & Boyden, E. S. (2019) · Nature Methods · doi:10.1038/s41592-018-0219-4 · Cited by 468
Riedl, A., Schlederer, M., Pudelko, K., Stadler, M., Walter, S., Unterleuthner, D., Unger, C., Kramer, N., Hengstschläger, M., Kenner, L., et al. (2016) · Journal of Cell Science · doi:10.1242/jcs.188102 · Cited by 389
Hickman, J. A., Graeser, R., de Hoogt, R., Vidic, S., Brito, C., Gutekunst, M., van der Kuip, H., & IMI PREDECT consortium (2014) · Biotechnology Journal · doi:10.1002/biot.201300492 · Cited by 380
Widespread intraspecies cross-contamination of human tumor cell lines arising at source
MacLeod, R. A. F., Dirks, W. G., Matsuo, Y., Kaufmann, M., Milch, H., & Drexler, H. G. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19991112)83:4<555::aid-ijc19>3.0.co;2-2 · Cited by 364
Modulation of secreted proteins of mouse mammary epithelial cells by the collagenous substrata.
Lee, E. Y., Parry, G., & Bissell, M. J. (1984) · The Journal of cell biology · doi:10.1083/jcb.98.1.146 · Cited by 320
3D bioprinted glioma stem cells for brain tumor model and applications of drug susceptibility
Dai, X., Ma, C., Lan, Q., & Xu, T. (2016) · Biofabrication · doi:10.1088/1758-5090/8/4/045005 · Cited by 301
One mouse, one patient paradigm: New avatars of personalized cancer therapy
Malaney, P., Nicosia, S. V., & Davé, V. (2014) · Cancer Letters · doi:10.1016/j.canlet.2013.10.010 · Cited by 289
Personalized Cancer Medicine: An Organoid Approach
Aboulkheyr Es, H., Montazeri, L., Aref, A. R., Vosough, M., & Baharvand, H. (2018) · Trends in Biotechnology · doi:10.1016/j.tibtech.2017.12.005 · Cited by 275
Applications of 3D printing in healthcare
Dodziuk, H. (2016) · Polish Journal of Cardio-Thoracic Surgery · doi:10.5114/kitp.2016.62625 · Cited by 272
AlgiMatrix™ Based 3D Cell Culture System as an In-Vitro Tumor Model for Anticancer Studies
Godugu, C., Patel, A. R., Desai, U., Andey, T., Sams, A., & Singh, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053708 · Cited by 234
Scaffold-Free Three-Dimensional Cell Culture Utilizing Micromolded Nonadhesive Hydrogels
Napolitano, A. P., Dean, D. M., Man, A. J., Youssef, J., Ho, D. N., Rago, A. P., Lech, M. P., & Morgan, J. R. (2007) · BioTechniques · doi:10.2144/000112591 · Cited by 231
3D-3-culture: a tool to unveil macrophage plasticity in the tumour microenvironment
Rebelo, S. P., Pinto, C., Martins, T. R., Harrer, N., Estrada, M. F., Loza-Alvarez, P., Cabeçadas, J., Alves, P. M., Gualda, E. J., Sommergruber, W., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.02.030 · Cited by 227
Organ-on-chip models of cancer metastasis for future personalized medicine: From chip to the patient
Caballero, D., Kaushik, S., Correlo, V. M., Oliveira, J. M., Reis, R. L., & Kundu, S. C. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.10.005 · Cited by 221
Self-citationInvasive three-dimensional organotypic neoplasia from multiple normal human epithelia
Ridky, T. W., Chow, J. M., Wong, D. J., & Khavari, P. A. (2010) · Nature Medicine · doi:10.1038/nm.2265 · Cited by 217
3D tumor models: History, advances and future perspectives
Benien, P., & Swami, A. (2014) · Future Oncology · doi:10.2217/fon.13.274 · Cited by 208
3D bioprinted mammary organoids and tumoroids in human mammary derived ECM hydrogels
Mollica, P. A., Booth-Creech, E. N., Reid, J. A., Zamponi, M., Sullivan, S. M., Palmer, X.-L., Sachs, P. C., & Bruno, R. D. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.06.017 · Cited by 206
Burden, N., Chapman, K. L., Sewell, F. R., & Robinson, V. (2015) · PubMed · Cited by 188
Engineering 3D Hydrogels for Personalized In Vitro Human Tissue Models
Liaw, C., Ji, S., & Guvendiren, M. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201701165 · Cited by 170
Hydrogels for 3D mammalian cell culture: a starting guide for laboratory practice
Ruedinger, F., Lavrentieva, A., Blume, C., Pepelanova, I., & Scheper, T. (2015) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-014-6253-y · Cited by 166
A three-dimensional spheroidal cancer model based on PEG-fibrinogen hydrogel microspheres
Pradhan, S., Clary, J. M., Seliktar, D., & Lipke, E. A. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2016.10.052 · Cited by 161
A novel 3D human glioblastoma cell culture system for modeling drug and radiation responses
Gomez-Roman, N., Stevenson, K. H., Gilmour, L., Hamilton, G. M., & Chalmers, A. J. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now164 · Cited by 156
3D bioprinting: improving in vitro models of metastasis with heterogeneous tumor microenvironments
Albritton, J. L., & Miller, J. S. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.025049 · Cited by 154
More than 3Rs: The importance of scientific validity for harm-benefit analysis of animal research
Würbel, H. (2017) · Lab Animal · doi:10.1038/laban.1220 · Cited by 152
Lu, S., Cuzzucoli, F., Jiang, J., Liang, L.-G., Wang, Y., Kong, M., Zhao, X., Cui, W., Li, J., & Wang, S. (2018) · Lab on a Chip · doi:10.1039/c8lc00852c · Cited by 144
Herter, S., Morra, L., Schlenker, R., Sulcova, J., Fahrni, L., Waldhauer, I., Lehmann, S., Reisländer, T., Agarkova, I., Kelm, J. M., et al. (2017) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-016-1927-1 · Cited by 138
Therapy response testing of breast cancer in a 3D high-throughput perfused microfluidic platform
Lanz, H. L., Saleh, A., Kramer, B., Cairns, J., Ng, C. P., Yu, J., Trietsch, S. J., Hankemeier, T., Joore, J., Vulto, P., et al. (2017) · BMC Cancer · doi:10.1186/s12885-017-3709-3 · Cited by 135
Patient-derived organoid models help define personalized management of gastrointestinal cancer
Aberle, M. R., Burkhart, R. A., Tiriac, H., Olde Damink, S. W. M., Dejong, C. H. C., Tuveson, D. A., & van Dam, R. M. (2018) · British Journal of Surgery · doi:10.1002/bjs.10726 · Cited by 135
Santo, V. E., Estrada, M. F., Rebelo, S. P., Abreu, S. C., Silva, I., Pinto, C., Veloso, S. C., Serra, T., Boghaert, E. R., Alves, P. M., et al. (2016) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2016.01.031 · Cited by 133
Yu, C., Kornmuller, A., Brown, C. F. C., Hoare, T. R., & Flynn, L. E. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.12.017 · Cited by 132
Sood, D., Tang‐Schomer, M. D., Pouli, D., Mizzoni, C., Raia, N. R., Tai, A., Arkun, K., Wu, J. K., Black, L. D., Scheffler, B., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12420-1 · Cited by 128
Cancer-on-a-chip systems at the frontier of nanomedicine
Zhang, Y. S., Zhang, Y.-N., & Zhang, W. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.03.011 · Cited by 127
Impact of the spheroid model complexity on drug response
Hoffmann, O. I., Ilmberger, C., Magosch, S., Joka, M., Jauch, K.-W., & Mayer, B. (2015) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2015.02.029 · Cited by 125
Evaluating Biomaterial- and Microfluidic-Based 3D Tumor Models
Carvalho, M. R., Lima, D., Reis, R. L., Correlo, V. M., & Oliveira, J. M. (2015) · Trends in biotechnology · doi:10.1016/j.tibtech.2015.09.009 · Cited by 122
Self-citationBarriers and facilitators to nursing handoffs: Recommendations for redesign
Welsh, C. A., Flanagan, M., & Ebright, P. R. (2010) · Nursing Outlook · doi:10.1016/j.outlook.2009.10.005 · Cited by 119
Skardal, A., Mack, D., Atala, A., & Soker, S. (2013) · Journal of the Mechanical Behavior of Biomedical Materials · doi:10.1016/j.jmbbm.2012.10.001 · Cited by 118
Estrada, M. F., Rebelo, S. P., Davies, E. J., Pinto, M. T., Pereira, H., Santo, V. E., Smalley, M. J., Barry, S. T., Gualda, E. J., Alves, P. M., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2015.11.030 · Cited by 113
Gioiella, F., Urciuolo, F., Imparato, G., Brancato, V., & Netti, P. A. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201600772 · Cited by 112
Self-citationMicrodosing and Other Phase 0 Clinical Trials: Facilitating Translation in Drug Development
Burt, T., Yoshida, K. J., Lappin, G., Vuong, L. T., John, C. S., de Wildt, S. N., Sugiyama, Y., & Rowland, M. (2016) · Clinical and Translational Science · doi:10.1111/cts.12390 · Cited by 100
Recent advances in microfluidic 3D cellular scaffolds for drug assays
Wu, J., Chen, Q., Liu, W., He, Z., & Lin, J. (2016) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2016.11.009 · Cited by 99
Talukdar, S., & Kundu, S. C. (2012) · Advanced Functional Materials · doi:10.1002/adfm.201200375 · Cited by 95
Self-citationFlow Characterization of a Spinner Flask for Induced Pluripotent Stem Cell Culture Application
Ismadi, M.-Z., Gupta, P., Fouras, A., Verma, P., Jadhav, S., Bellare, J., & Hourigan, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106493 · Cited by 93
Hydrogel-Based 3D Model of Patient-Derived Prostate Xenograft Tumors Suitable for Drug Screening
Fong, E., Martinez, M., Yang, J., Mikos, A., Navone, N., Harrington, D., & Farach-Carson, M. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500085p · Cited by 91
Bano, S., Dey, T., Sharma, S., & Kundu, S. C. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/am506094c · Cited by 87
Self-citationPolymeric Biomaterials for In Vitro Cancer Tissue Engineering and Drug Testing Applications
Pradhan, S., Hassani, I., Clary, J. M., & Lipke, E. A. (2016) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2015.0567 · Cited by 86
Bioengineered tumoral microtissues recapitulate desmoplastic reaction of pancreatic cancer
Brancato, V., Comunanza, V., Imparato, G., Corà, D., Urciuolo, F., Noghero, A., Bussolino, F., & Netti, P. A. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.11.072 · Cited by 82
Self-citation2.11 Polymers of Biological Origin ☆
Silva, S. S., Fernandes, E. M., Pina, S., Silva‐Correia, J., Vieira, S., Oliveira, J. M., & Reis, R. L. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803581-8.10134-1 · Cited by 82
Self-citationMulti-Omics Profiling of the Tumor Microenvironment: Paving the Way to Precision Immuno-Oncology
Finotello, F., & Eduati, F. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00430 · Cited by 81
Jin, Q., Liu, G., Li, S., Yuan, H., Yun, Z., Zhang, W., Zhang, S., Dai, Y., & Ma, Y. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.26782 · Cited by 79
Metabolism during ECM Detachment: Achilles Heel of Cancer Cells?
Mason, J. A., Hagel, K. R., Hawk, M. A., & Schafer, Z. T. (2017) · Trends in Cancer · doi:10.1016/j.trecan.2017.04.009 · Cited by 78
Three-dimensional bio-printing: A new frontier in oncology research
Charbe, N. B., McCarron, P. A., & Tambuwala, M. M. (2017) · World Journal of Clinical Oncology · doi:10.5306/wjco.v8.i1.21 · Cited by 78
A 1536-Well 3D Viability Assay to Assess the Cytotoxic Effect of Drugs on Spheroids
Madoux, F., Tanner, A., Vessels, M., Willetts, L., Hou, S., Scampavia, L., & Spicer, T. P. (2017) · SLAS Discovery · doi:10.1177/2472555216686308 · Cited by 72
Shekaran, A., Lam, A. T., Sim, E., Lee, J., Li, J., Wen, J. T. P., Chan, J. K. Y., Choolani, M. A., Reuveny, S., Birch, W. R., et al. (2016) · Cytotherapy · doi:10.1016/j.jcyt.2016.06.016 · Cited by 71
Lam, A. T., Li, J., Toh, J. P. W., Sim, E., Chen, A. K.-L., Chan, J. K. Y., Choolani, M. A., Reuveny, S., Birch, W. R., & Oh, S. (2016) · Cytotherapy · doi:10.1016/j.jcyt.2016.11.009 · Cited by 71
Mix-ups and mycoplasma: the enemies within
Drexler, H. G., Uphoff, C. C., Dirks, W. G., & MacLeod, R. A. F. (2002) · Leukemia Research · doi:10.1016/s0145-2126(01)00136-9 · Cited by 66
Cellular self-assembly and biomaterials-based organoid models of development and diseases
Shah, S. B., & Singh, A. K. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.01.075 · Cited by 66
Bersani, F., Lee, J. W., Yu, M., Morris, R. T., Desai, R. N., Ramaswamy, S., Toner, M., Haber, D. A., & Parekkadan, B. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1809 · Cited by 65
Phan-Lai, V., Florczyk, S. J., Kievit, F. M., Wang, K., Gad, E., Disis, M. L., & Zhang, M. (2013) · Biomacromolecules · doi:10.1021/bm301928u · Cited by 63
Investigations into the cancer stem cell niche using in-vitro 3-D tumor models and microfluidics
Sreepadmanabh, M., & Toley, B. J. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.03.009 · Cited by 60
Cacopardo, L., Costa, J. S., Giusti, S., Buoncompagni, L., Meucci, S., Corti, A., Mattei, G., & Ahluwalia, A. D. (2019) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2019.111340 · Cited by 60
Zhuo, S., Chen, J., Xie, S., Hong, Z., & Jiang, X. (2009) · Journal of Biomedical Optics · doi:10.1117/1.3088029 · Cited by 56
Functional Cells Cultured on Microcarriers for Use in Regenerative Medicine Research
Sun, L., Lin, S., Li, Y.-S., Harn, H., & Chiou, T. (2010) · Cell Transplantation · doi:10.3727/096368910x532792 · Cited by 55
Anastasov, N., Höfig, I., Radulović, V., Ströbel, S., Salomon, M., Lichtenberg, J., Rothenaigner, I., Hadian, K., Kelm, J. M., Thirion, C., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1481-9 · Cited by 55
Thoma, C. R., Stroebel, S., Rösch, N., Calpe, B., Krek, W., & Kelm, J. M. (2013) · SLAS Discovery · doi:10.1177/1087057113499071 · Cited by 54
Kundu, B., Saha, P., Datta, K., & Kundu, S. C. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.08.047 · Cited by 52
Self-citationPeck, Y., & Wang, D. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.751096 · Cited by 52
Singh, A. K., Brito, I., & Lammerding, J. (2018) · Trends in cancer · doi:10.1016/j.trecan.2018.01.008 · Cited by 49
3D is not enough: Building up a cell instructive microenvironment for tumoral stroma microtissues
Brancato, V., Garziano, A., Gioiella, F., Urciuolo, F., Imparato, G., Panzetta, V., Fusco, S., & Netti, P. A. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.10.007 · Cited by 47
Self-citationThe mice with human tumours: Growing pains for a popular cancer model
Willyard, C. (2018) · Nature · doi:10.1038/d41586-018-05890-8 · Cited by 47
Spinner-flask culture induces redifferentiation of de-differentiated chondrocytes
Lee, T., Bhang, S. H., La, W.-G., Yang, H. S., Seong, J. Y., Lee, H., Im, G., Lee, S., & Kim, B. (2010) · Biotechnology Letters · doi:10.1007/s10529-010-0488-1 · Cited by 44
Anti-Cancer Drug Validation: the Contribution of Tissue Engineered Models
Carvalho, M. R., Lima, D., Reis, R. L., Oliveira, J. M., & Correlo, V. M. (2017) · Stem Cell Reviews and Reports · doi:10.1007/s12015-017-9720-x · Cited by 44
Self-citationApplications of 3D Printing in Cancer
Serrano, D. R., Terres, M. C., & Lalatsa, A. (2018) · Journal of 3D Printing in Medicine · doi:10.2217/3dp-2018-0007 · Cited by 41
Into the Depths: Techniques for in Vitro Three-Dimensional Microtissue Visualization
Kabadi, P. K., Vantangoli, M. M., Rodd, A. L., Leary, E., Madnick, S. J., Morgan, J. R., Kane, A. B., & Boekelheide, K. (2015) · BioTechniques · doi:10.2144/000114353 · Cited by 39
Bioreactor-Based Tumor Tissue Engineering
Guller, A., Grebenyuk, P. N., Shekhter, A. B., Zvyagin, A. V., & Deyev, S. M. (2016) · Acta Naturae · doi:10.32607/20758251-2016-8-3-44-58 · Cited by 38
Boghaert, E. R., Lu, X. L., Hessler, P., McGonigal, T. P., Oleksijew, A., Mitten, M. J., Foster-Duke, K. D., Hickson, J. A., Santo, V. E., Brito, C., et al. (2017) · Neoplasia · doi:10.1016/j.neo.2017.06.004 · Cited by 37
Brancato, V., Gioiella, F., Profeta, M., Imparato, G., Guarnieri, D., Urciuolo, F., Melone, P., & Netti, P. A. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.05.004 · Cited by 35
Self-citationA High-Throughput Screening Model of the Tumor Microenvironment for Ovarian Cancer Cell Growth
Lal-Nag, M., McGee, L., Guha, R., Lengyel, E., Kenny, H. A., & Ferrer, M. (2017) · SLAS Discovery · doi:10.1177/2472555216687082 · Cited by 33
Cancer drug discovery: recent innovative approaches to tumor modeling
Lovitt, C. J., Shelper, T., & Avery, V. M. (2016) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2016.1214562 · Cited by 31
Gamerith, G., Rainer, J., Huber, J., Hackl, H., Trajanoski, Z., Koeck, S., Lorenz, E., Kern, J., Kofler, R., Kelm, J. M., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.22636 · Cited by 30
Yeung, P., Sin, H. S., Chan, S., Chan, G., & Chan, B. P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144139 · Cited by 28
Modeling Human Immunity In Vitro : Improving Artificial Lymph Node Physiology by Stromal Cells
Sardi, M., Lubitz, A., & Giese, C. (2016) · Applied In Vitro Toxicology · doi:10.1089/aivt.2016.0004 · Cited by 19
Li, C., Zhao, S. Z., Zhao, Y., Qian, Y., Li, J., & Yin, Y. (2014) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.33150 · Cited by 18
Lü, W., Sun, R., Hu, Y., Lu, J.-R., Gu, L., Liu, Z., Lei, G., Qiang, Z., & Cai, L. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.03.020 · Cited by 18
Phase 0 Trials: Expediting the Development of Chemoprevention Agents
Kummar, S., & Doroshow, J. H. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0013 · Cited by 14
A straightforward method to produce decellularized dermis-based matrices for tumour cell cultures
Brancato, V., Ventre, M., Imparato, G., Urciuolo, F., Meo, C., & Netti, P. A. (2016) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2350 · Cited by 10
Self-citation
Cited by
Li, Z., Lai, X., Fu, S., Ren, L., Cai, H., Zhang, H., Gu, Z., Ma, X., & Luo, K. (2022) · Advanced Science · doi:10.1002/advs.202201734 · Cited by 680
Current hurdles to the translation of nanomedicines from bench to the clinic
Đorđević, S., Gonzalez, M. M., Conejos-Sánchez, I., Carreira, B., Pozzi, S., Acúrcio, R. C., Satchi-Fainaro, R., Florindo, H. F., & Vicent, M. J. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-01024-2 · Cited by 657
Lv, Y., Wang, H., Li, G., & Zhao, B. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.02.004 · Cited by 67
3D fluid-dynamic ovarian cancer model resembling systemic drug administration for efficacy assay
Marrella, A. (2020) · ALTEX · doi:10.14573/altex.2003131 · Cited by 36
Xu, Y., Qi, J., Zhou, W., Liu, X., Zhang, L., Yao, X., & Wu, H. (2022) · Bio-Design and Manufacturing · doi:10.1007/s42242-022-00204-4 · Cited by 15
Metadata
- Authors
- Brancato, V., Oliveira, J. M., Correlo, V. M., Reis, R. L., & Kundu, S. C.
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2020-02
- Volume
- 232
- Pages
- 119744
- ISSN
- 0142-9612 (ISSN-L)
- OpenAlex
- W2996862224
- Cited by
- 281
- References
- 111
- FWCI
- 9.29
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.